HAVCR2 and B-cell chronic lymphocytic leukemia: In agreement to this finding, our recent studies displayed more expression of Tim-3 and PD-1 on both CD4+ and CD8+ T cells from patients with CLL (Allahmoradi et al., 2017; Taghiloo et al., 2017).